14-50908981-TA-TAA

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_002863.5(PYGL):​c.2178-27dupT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.291 in 1,531,846 control chromosomes in the GnomAD database, including 72,991 homozygotes. Variant has been reported in ClinVar as Likely benign (★★). There are indicators that this mutation may affect the branch point..

Frequency

Genomes: 𝑓 0.35 ( 10267 hom., cov: 0)
Exomes 𝑓: 0.28 ( 62724 hom. )

Consequence

PYGL
NM_002863.5 intron

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.780

Publications

5 publications found
Variant links:
Genes affected
PYGL (HGNC:9725): (glycogen phosphorylase L) This gene encodes a homodimeric protein that catalyses the cleavage of alpha-1,4-glucosidic bonds to release glucose-1-phosphate from liver glycogen stores. This protein switches from inactive phosphorylase B to active phosphorylase A by phosphorylation of serine residue 15. Activity of this enzyme is further regulated by multiple allosteric effectors and hormonal controls. Humans have three glycogen phosphorylase genes that encode distinct isozymes that are primarily expressed in liver, brain and muscle, respectively. The liver isozyme serves the glycemic demands of the body in general while the brain and muscle isozymes supply just those tissues. In glycogen storage disease type VI, also known as Hers disease, mutations in liver glycogen phosphorylase inhibit the conversion of glycogen to glucose and results in moderate hypoglycemia, mild ketosis, growth retardation and hepatomegaly. Alternative splicing results in multiple transcript variants encoding different isoforms.[provided by RefSeq, Feb 2011]
PYGL Gene-Disease associations (from GenCC):
  • glycogen storage disease VI
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia, Genomics England PanelApp, Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 14-50908981-T-TA is Benign according to our data. Variant chr14-50908981-T-TA is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 258838.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.538 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PYGLNM_002863.5 linkc.2178-27dupT intron_variant Intron 17 of 19 ENST00000216392.8 NP_002854.3 P06737-1
PYGLNM_001163940.2 linkc.2076-27dupT intron_variant Intron 16 of 18 NP_001157412.1 P06737-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PYGLENST00000216392.8 linkc.2178-27_2178-26insT intron_variant Intron 17 of 19 1 NM_002863.5 ENSP00000216392.7 P06737-1
PYGLENST00000532462.5 linkc.2178-27_2178-26insT intron_variant Intron 17 of 19 1 ENSP00000431657.1 E9PK47
PYGLENST00000544180.6 linkc.2076-27_2076-26insT intron_variant Intron 16 of 18 2 ENSP00000443787.1 P06737-2
PYGLENST00000532107.2 linkn.351-27_351-26insT intron_variant Intron 2 of 3 5

Frequencies

GnomAD3 genomes
AF:
0.352
AC:
53206
AN:
151026
Hom.:
10238
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.453
Gnomad AMI
AF:
0.115
Gnomad AMR
AF:
0.448
Gnomad ASJ
AF:
0.243
Gnomad EAS
AF:
0.556
Gnomad SAS
AF:
0.348
Gnomad FIN
AF:
0.289
Gnomad MID
AF:
0.430
Gnomad NFE
AF:
0.273
Gnomad OTH
AF:
0.361
GnomAD2 exomes
AF:
0.356
AC:
88857
AN:
249322
AF XY:
0.344
show subpopulations
Gnomad AFR exome
AF:
0.450
Gnomad AMR exome
AF:
0.573
Gnomad ASJ exome
AF:
0.243
Gnomad EAS exome
AF:
0.553
Gnomad FIN exome
AF:
0.291
Gnomad NFE exome
AF:
0.273
Gnomad OTH exome
AF:
0.327
GnomAD4 exome
AF:
0.284
AC:
392300
AN:
1380708
Hom.:
62724
Cov.:
33
AF XY:
0.285
AC XY:
196783
AN XY:
690496
show subpopulations
African (AFR)
AF:
0.446
AC:
13782
AN:
30900
American (AMR)
AF:
0.553
AC:
24327
AN:
43958
Ashkenazi Jewish (ASJ)
AF:
0.243
AC:
6171
AN:
25398
East Asian (EAS)
AF:
0.551
AC:
20909
AN:
37930
South Asian (SAS)
AF:
0.332
AC:
27986
AN:
84318
European-Finnish (FIN)
AF:
0.276
AC:
14163
AN:
51348
Middle Eastern (MID)
AF:
0.370
AC:
2070
AN:
5594
European-Non Finnish (NFE)
AF:
0.254
AC:
265333
AN:
1044242
Other (OTH)
AF:
0.308
AC:
17559
AN:
57020
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
11897
23795
35692
47590
59487
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8874
17748
26622
35496
44370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.353
AC:
53277
AN:
151138
Hom.:
10267
Cov.:
0
AF XY:
0.357
AC XY:
26338
AN XY:
73864
show subpopulations
African (AFR)
AF:
0.453
AC:
18595
AN:
41050
American (AMR)
AF:
0.448
AC:
6813
AN:
15196
Ashkenazi Jewish (ASJ)
AF:
0.243
AC:
841
AN:
3466
East Asian (EAS)
AF:
0.555
AC:
2833
AN:
5106
South Asian (SAS)
AF:
0.347
AC:
1658
AN:
4774
European-Finnish (FIN)
AF:
0.289
AC:
3000
AN:
10368
Middle Eastern (MID)
AF:
0.432
AC:
127
AN:
294
European-Non Finnish (NFE)
AF:
0.273
AC:
18544
AN:
67868
Other (OTH)
AF:
0.362
AC:
761
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1570
3140
4710
6280
7850
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
514
1028
1542
2056
2570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.204
Hom.:
535

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 13, 2017
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 14, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.78
BranchPoint Hunter
1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11414268; hg19: chr14-51375699; API